Congratulations to our

2024 travel grant recipients! 

Fawaz Saleh

University of Hannover, Germany

Abstract Title: Scalable Generation of Human IPSC-Derived Natural Killer and Dendritic Cells Using A Continuous Concurrent Production Platform.

"I am deeply honored to receive the prestigious travel grant from Proteintechfor the ISSCR 2024 Annual Meeting in Hamburg! This incredible opportunity allows me to share my research on a grand stage and engage with brilliant scientists from around the globe. I am immensely grateful for this chance to expand my knowledge, network with fellow researchers, and immerse myself in the latest scientific advancements. Thank you, Proteintech, for making this possible!"

Summary of Abstract:

Fawaz Saleh has revolutionized cell manufacturing with a cutting-edge platform using human iPSC technology. This innovative system enables the continuous production of iPSC-derived  Natural Killer cells (iNKs) and Dendritic cells (iDCs) for several months. The platform provides new insights into NK cell development. Additionally, the generated iNKs have shown remarkable efficacy in targeting and killing cancer cells. Meanwhile, the iDCs effectively stimulate effector memory and central memory phenotypes in CMV-positive patients. These groundbreaking early proof-of-concept approaches open up exciting new avenues for immune cell farming and next-generation biotherapeutics.

Homa Majd

University of California, San Francisco

Abstract Title: Developing hPSC-based Drug Screening and Cell Therapy Platforms for Enteric Neruopathies.

"I am thrilled to receive the Proteintech Travel Grant for attending the 2024 ISSCR Annual Meeting in Hamburg, Germany. With this award (and their antibodies!), I can present my research on peripheral neuropathies at one of the most prestigious stem cell conferences, engage with experts in the field, and explore new scientific advancements. I am grateful for this opportunity and look forward to contributing to the conference."

Summary of Abstract: 

Gastrointestinal (GI) motility disorders represent a significant medical challenge, as current therapeutic options are lacking. Leveraging our innovative hPSC-derived enteric nervous system (ENS) we have developed a platform for therapeutic targeting of GI motility disorders.

Thank you to all who entered for the 2024 Travel Grant. The abstract submission period has now closed. 

Support

Videos

Protocols

Pathway Posters Library

Early Career Researcher Hub

Terms and conditions

1. Only applicants from Universities and Research Institutions are eligible to take part in this competition.

2. This award will cover only the cost of registration, accommodation, and transport to the ISSCR 2024 meeting, to the total value of $1,000 USD or equivallent. Any remaining balance available after these costs have been covered is not transferable and cannot be used for other expenses.

3. By taking part in the competition, you agree to take part in any marketing and PR activities that Proteintech deem necessary. These may include the following: An interview, featuring on Proteintech blog/website, and  associated press releases.

4. The deadline for abstracts to be submitted is May 22nd, 2024. Any applications submitted after this date will not be eligible.

5. Applicants can only submit one entry. Any further entries will not be eligible. Applicants must complete the application form in full.

6. The applicant must be available to attend the ISSCR meeting in Hamburg, Germany. The travel grant applies only to the ISSCR 2024 meeting. The reimbursement cannot be used for any other meeting.

7. The winning applicants will receive this travel grant via reimbursement from Proteintech Group. The recipient must provide receipts for their ISSCR registration, accommodation, and travel to receive reimbursement.   

8. The recipient will receive reimbursement within 7 days of proof of expense being obtained.

9. The reimbursement can only be paid to the individual or institution that originally paid for the travel expenses, registration, and accommodation.

10. The winners will be decided by the Proteintech scientific writing team and an assisting group of scientific peers. The winning entries will be the abstract deemed most interesting by the panel.

11. Should the event have to be canceled for any reason, the winner will receive their prize in the form of a research grant, instead of a travel grant.

12. The decision on which applicants win is at the discretion of Proteintech Group and their decision is final.

13. This competition is not affiliated with ISSCR in any way.